top of page

KRAS Cancer News & Updates



Cancer Treatment & Clinical Trial Eligibility: What Patients Need to Know
Once you know your options, the next question is: Am I eligible? Here’s how doctors typically determine if a patient qualifies for a clinical trial or specific therapy—regardless of cancer type.
6 things that matter...

Terri Conneran KRAS Kickers
Jul 11


What Every Cancer Patient Should Know About Today’s Treatment Options
..just been diagnosed—or are navigating next step—you’re not alone. Cancer care has changed dramatically in the last decade. Today, you may have more treatment choices than ever before. This post is designed to help you understand your options and feel confident asking the right questions.

Terri Conneran KRAS Kickers
Jul 11


Val: A Life of Courage, Faith, and Hope
Val’s Advice to Others Facing Lung Cancer
...a quiet but powerful advocate, offering guidance to other people, especially young adults with cancer:
“Don’t freak out when you’re diagnosed. And don’t go straight to Google. Statistics don’t define you
KRAS Cancer Connect
6 days ago


What Is ASCO Conference—And Should Cancer Patients Care?
💡 Why It Matters to Patients:
Even if you’re not in the room, what happens at ASCO can shape your treatment options—now and in the future. KRAS-driven cancers (lung, colon, pancreatic, and rare cancers) are a major area of focus at ASCO. knowing what’s coming can help you:
-Ask better questions -
-Stay ahead of the curve -
-Find hope in options you didn’t know existed- Gen-Me Medicine—where cancer care is about matching the right treatment to your unique molecular fingerpri

Terri Conneran KRAS Kickers
Jun 10


Precision Medicine has Empowered Cancer Patients
One of the patient voices from this documentary is Terri Conneran: Empowering the Patients For Precision Cancer Advocacy In the documentary, powerful stories from patients, industry experts, and healthcare providers about how precision medicine has empowered their healthcare decisions, providing renewed hope .


Why AML Treatments Don’t Always Work—and What This Study Reveals About KRAS, NPM1, and Monocytic Resistance
By KRAS Kickers – Cancer Knowledge + Research + Advocacy = Survivorship 📅 May 2025 | 🧬 Published in Blood Cancer Discovery 🔬...

Terri Conneran KRAS Kickers
May 22


Rare Pancreas cancer FGFR + KRAS trial - comes to you
Rare Pancreatic cancer trial comes to you! FGFR + KRAS

Terri Conneran KRAS Kickers
May 19


LGSOC Cancer Treatment FDA Fast Tracked
Low-Grade Serous Ovarian Cancer (LGSOC)Â is a rare, slow-growing type of ovarian cancer. It starts in the cells lining the ovaries, fallopian tubes, or peritoneum ...


Lung & Pancreatic cancer Patient Knowledge of Research
KRAS Kickers is a cancer patient-led nonprofit organization that shares Knowledge of publicly available Research to empower patients and caregivers to Advocate for Survivorship.
Our goal to kick cancer's KRAS!
Cancer Treatment & Clinical Trial Eligibility: What Patients Need to Know
Once you know your options, the next question is: Am I eligible? Here’s how doctors typically determine if a patient qualifies for a clinical trial or specific therapy—regardless of cancer type.
6 things that matter...
What Every Cancer Patient Should Know About Today’s Treatment Options
..just been diagnosed—or are navigating next step—you’re not alone. Cancer care has changed dramatically in the last decade. Today, you may have more treatment choices than ever before. This post is designed to help you understand your options and feel confident asking the right questions.
Val: A Life of Courage, Faith, and Hope
Val’s Advice to Others Facing Lung Cancer
...a quiet but powerful advocate, offering guidance to other people, especially young adults with cancer:
“Don’t freak out when you’re diagnosed. And don’t go straight to Google. Statistics don’t define you
bottom of page